We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.
- Authors
Lustig, R H; Greenway, F; Velasquez-Mieyer, P; Heimburger, D; Schumacher, D; Smith, D; Smith, W; Soler, N; Warsi, G; Berg, W; Maloney, J; Benedetto, J; Zhu, W; Hohneker, J
- Abstract
To compare changes in weight in obese patients who received long-acting octreotide (octreotide LAR) at one of three dose levels (20, 40, or 60 mg) or placebo over 6 months and to identify the lowest dose of octreotide LAR that safely achieved optimal weight loss.
- Publication
International journal of obesity (2005), 2006, Vol 30, Issue 2, p331
- ISSN
0307-0565
- Publication type
Journal Article
- DOI
10.1038/sj.ijo.0803074